Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysis
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12957-024-03382-w
Published Online: 2024-04-20
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Xia, Lin-Yu
Cao, Xu-Chen
Yu, Yue
Text and Data Mining valid from 2024-04-20
Version of Record valid from 2024-04-20
Article History
Received: 2 February 2024
Accepted: 6 April 2024
First Online: 20 April 2024
Declarations
:
: The authors declare no competing interests.
: Not applicable.